The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung Disease

This is a study of the lung health of the population of Vancouver and the extent of, and the risk factors for, chronic obstructive lung disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Obstructive Lung Disease Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

40 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

St.Paul's Hospital/Providence Health Care

Vancouver, British Columbia, V5Z 1L8, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

40 years of age and older
Both sexes
Random sample of population

Exclusion criteria

Contraindication for lung function testing and serious life threatening illness.

Treatment and study plan

Study to determine the burden of disease

Behavioral

Primary outcomes

Lung health

Time frame: 10 years

Lung health of the population of Vancouver and the extent of, and the risk factors for, chronic obstructive lung disease

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Official study title

The Burden of Chronic Obstructive Lung Disease (BOLD) Study

Important dates

Study start: 2005
Primary completion: 2013
Study completion: 2013
First posted: Aug 26, 2005
Registry last updated: Feb 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed